# FDA recall D-66295-001

> **Hospira Inc.** · Class II · drug recall initiated 2013-09-05.

## Product

0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj., 10 mL, Single-Dose Vial, NDC 0409-9045-01, Hospira, Inc., Lake Forest, IL 60045

## Reason for recall

Lack of Assurance of Sterility; potential for vial breakage

## Distribution

Nationwide and Guam and Abu Dhabi

## Key facts

- **Recall number:** D-66295-001
- **Recalling firm:** Hospira Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-09-05
- **Report date:** 2013-10-16
- **Termination date:** 2014-10-28

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-66295-001

## Citation

> AI Analytics. FDA recall D-66295-001. Retrieved 2026-06-26 from https://api.ai-analytics.org/recall/D-66295-001. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*